Operating Lease, Liability, Current of BIO-RAD LABORATORIES, INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
BIO-RAD LABORATORIES, INC. quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • BIO-RAD LABORATORIES, INC. Operating Lease, Liability, Current for the quarter ending 30 Sep 2025 was $36,800,000, a 14% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $36,800,000 -$6,034,000 -14% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $39,300,000 -$2,213,000 -5.3% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $41,300,000 +$1,262,000 +3.2% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $41,700,000 +$1,300,000 +3.2% 31 Dec 2024 10-Q 29 Oct 2025 2025 Q3
Q3 2024 $42,834,000 +$3,718,000 +9.5% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $41,513,000 +$4,970,000 +14% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $40,038,000 +$3,889,000 +11% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $40,400,000 +$4,064,000 +11% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $39,116,000 +$5,073,000 +15% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $36,543,000 +$808,000 +2.3% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $36,149,000 -$590,000 -1.6% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $36,336,000 -$99,000 -0.27% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $34,043,000 -$2,019,000 -5.6% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $35,735,000 +$127,000 +0.36% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $36,739,000 -$2,496,000 -6.4% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $36,435,000 -$72,000 -0.2% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $36,062,000 +$1,675,000 +4.9% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $35,608,000 +$1,667,000 +4.9% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $39,235,000 +$4,795,000 +14% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $36,507,000 +$1,142,000 +3.2% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $34,387,000 +$693,000 +2.1% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $33,941,000 +$8,000 +0.02% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $34,440,000 +$27,000 +0.08% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $35,365,000 +$35,365,000 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $33,694,000 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $33,933,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $34,413,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.